Market Closed -
Nasdaq
04:00:00 2024-06-26 pm EDT
5-day change
1st Jan Change
1.29
USD
-9.15%
-9.15%
-65.42%
Alpha Teknova, Inc. announced that it has received $20.904987 million in funding
On September 19, 2023, Alpha Teknova, Inc. closed the transaction. The company has raised $20,904,987 from 23 investors pursuant to regulation D.
Alpha Teknova, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 13
CI
Transcript : Alpha Teknova, Inc., Q1 2024 Earnings Call, May 13, 2024
May. 13
Earnings Flash (TKNO) ALPHA TEKNOVA Reports Q1 Revenue $9.3M, vs. Street Est of $8.62M
May. 13
MT
Alpha Teknova, Inc. Reiterates Revenue Guidance for Fiscal 2024
May. 13
CI
BTIG Downgrades Alpha Teknova to Neutral From Buy
Mar. 12
MT
Transcript : Alpha Teknova, Inc., Q4 2023 Earnings Call, Mar 11, 2024
Mar. 11
Alpha Teknova, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Mar. 11
CI
Alpha Teknova, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 11
CI
Earnings Flash (TKNO) ALPHA TEKNOVA Reports Q4 Revenue $7.9M, vs. Street Est of $8.3M
Mar. 11
MT
Alpha Teknova, Inc. Announces Impairment Charges for the Fourth Quarter Ended December 31, 2023
Mar. 11
CI
Alpha Teknova, Inc. Provides Earnings Guidance for the Full Year 2024
Mar. 11
CI
Alpha Teknova, Inc. Announces Termination of Certain Executive Officers, Effective from March 1, 2024
Jan. 16
CI
Transcript : Alpha Teknova, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Nov. 09
Alpha Teknova, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 09
CI
Earnings Flash (TKNO) ALPHA TEKNOVA Posts Q3 Revenue $8.2M, vs. Street Est of $8.2M
Nov. 09
MT
Alpha Teknova, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023
Nov. 09
CI
Alpha Teknova Insider Bought Shares Worth $1,499,999, According to a Recent SEC Filing
23-09-21
MT
Alpha Teknova Closes Registered Direct Offering, Private Placement With Gross Proceeds of $22.9 Million
23-09-19
MT
Alpha Teknova, Inc. announced that it has received $20.904987 million in funding
23-09-18
CI
Alpha Teknova Expects $22.9 Million Gross Proceeds From Registered Direct Offering, Private Placement
23-09-18
MT
Alpha Teknova, Inc. announced that it expects to receive $20.904987 million in funding
23-09-17
CI
Alpha Teknova, Inc. Announces the Appointment of Martha J. Demski to Its Board of Directors
23-08-16
CI
Alpha Teknova, Inc. Announces Executive Changes, Effective 31 , August 2023
23-08-14
CI
Transcript : Alpha Teknova, Inc., Q2 2023 Earnings Call, Aug 10, 2023
23-08-10
(TKNO) ALPHA TEKNOVA Forecasts Q2 Revenue $11.5M
23-08-10
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
More about the company
Last Close Price
1.42
USD
Average target price
5.5
USD
Spread / Average Target
+287.32%
Consensus
1st Jan change
Capi.
-65.42% 57.97M -8.90% 11.53B -12.79% 7.33B +26.65% 5.68B -17.87% 3.71B +7.41% 2.49B -65.15% 2.35B +28.63% 2.23B -11.56% 2.22B -14.32% 1.61B
Diagnostic & Testing Substances
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1